Evidence map›Paper›PMID 39496457›Full record

ArticleGenes & development2024

DNA-directed termination of mammalian RNA polymerase II.

Lee Davidson, Jérôme O Rouvière, Rui Sousa-Luís, Takayuki Nojima, Nicholas J Proudfoot, Torben Heick Jensen, Steven West

Abstract read
In one paragraph

Article in Genes & development, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lee Davidson *The Living Systems Institute, University of Exeter, Exeter EX4 4QD, United Kingdom.
Jérôme O Rouvière *Department of Molecular Biology and Genetics, Aarhus University, 8000C Aarhus, Denmark.
Rui Sousa-LuísSir William Dunn School of Pathology, Oxford OX1 3RE, United Kingdom.
Takayuki NojimaSir William Dunn School of Pathology, Oxford OX1 3RE, United Kingdom.
Nicholas J ProudfootSir William Dunn School of Pathology, Oxford OX1 3RE, United Kingdom.
Torben Heick JensenDepartment of Molecular Biology and Genetics, Aarhus University, 8000C Aarhus, Denmark; s.west@exeter.ac.uk thj@mbg.au.dk.
Steven WestThe Living Systems Institute, University of Exeter, Exeter EX4 4QD, United Kingdom; s.west@exeter.ac.uk thj@mbg.au.dk.

Funding

Wellcome Trust
6 · The paper itself

Abstract

The best-studied mechanism of eukaryotic RNA polymerase II (RNAPII) transcriptional termination involves polyadenylation site-directed cleavage of the nascent RNA. The RNAPII-associated cleavage product is then degraded by XRN2, dislodging RNAPII from the DNA template. In contrast, prokaryotic RNAP and eukaryotic RNAPIII often terminate directly at T-tracts in the coding DNA strand. Here, we demonstrate a similar and omnipresent capability for mammalian RNAPII. Importantly, this termination mechanism does not require upstream RNA cleavage. Accordingly, T-tract-dependent termination can take place when XRN2 cannot be engaged. We show that T-tracts can terminate snRNA transcription independently of RNA cleavage by the Integrator complex. Importantly, we found genome-wide termination at T-tracts in promoter-proximal regions but not within protein-coding gene bodies. XRN2-dependent termination dominates downstream from protein-coding genes, but the T-tract process is sometimes used. Overall, we demonstrate global DNA-directed attrition of RNAPII transcription, suggesting that RNAPs retain the potential to terminate over T-rich sequences throughout evolution.

Indexed as

RNA Polymerase IITranscription Termination, GeneticAnimalsDNAExoribonucleasesHumansPromoter Regions, GeneticTranscription, GeneticDNAExoribonucleasesRNA Polymerase IIXRN2 protein, humanexosomehistoneIntegratorRNA polymerase IIsnRNAtranscription terminationXrn2

Identifiers

PMID39496457
PMCPMC11610936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.